Skip to main content
. 2021 Apr 16;293:114166. doi: 10.1016/j.jviromet.2021.114166

Table 1.

Specificity and sensitivity of the method according to Ct values and different prevalence rates of the disease.


Sensitivity (%)
Specificity (%)
PPV (%)
NPV (%)

Positive samples (n) 95 % CI
Negative samples (n) 95 % CI
Prevalence
Prevalence
1% 5% 1% 5%
Total 102/110 92.7 86.2 96.8 133/136 97.8 93.7 99.5 29.8 68.9 99.9 99.6
Ct groups <20 22/22 100 84.6 100 31.4 70.5 100 100
20−25 22/22 100 84.6 100 31.4 70.5 100 100
25−30 22/22 100 84.6 100 31.4 70.5 100 100
30−35 21/22 95.5 77.2 100 30.4 69.5 100 99.8
<20−35 (total) 87/88 98.9 93.8 100 31.2 70.2 100 100
>35 15/22 68.2 45.1 86.1 23.8 61.9 99.7 98.3

● Sensitivity, that is the probability that a test result will be positive when the disease is present (true positive rate) was calculated for each group according to the following type: a / (a + b).

● Specificity, that is the probability that a test result will be negative when the disease is not present (true negative rate) was calculated according to the following type: d / (c + d).

● Positive predictive value, that is the probability that the disease is present when the test is positive was calculated for each group according to the following type:

PPV = Se x Prevalence / Se x Prevalence + (1-Sp) x (1-Prevalence).

● Negative predictive value, that is the probability that the disease is not present when the test is negative was calculated for each group according to the following type:

NPV = Sp x (1-Prevalence) / (1-Se) x Prevalence + Sp x (1-Prevalence).